Suven Life Sciences Gets Patents for Neurodegenerative Drug

New Delhi: Biopharmaceutical firm Suven Life Sciences on Tuesday said it has been granted one patent each by the US, Israel and Macau for a drug used in the treatment of neurodegenerative diseases. Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's. In a BSE filing, the company said it has been granted "one product patent from Israel, one product patent from Macau and one product patent from USA correspon...